Immune cell activation inhibitor and use thereof
AssigneeEhime University
InventorJunya Tanaka
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical that can be used widely for intractable neurological diseases, inflammatory diseases, etc. The immune cell activation inhibitor of the present invention contains bromovalerylurea or a derivative thereof. The immune cell activation inhibitor of the present invention can be used as a pharmaceutical for, for example: chronic neurological diseases such as Parkinson's disease and Alzheimer's disease; acute neurological diseases such as cerebral infarction and brain injury; and inflammatory diseases such as systemic inflammatory response syndromes.
Claims3
A method for treating an inflammatory disease, the method comprising a step of:
- administering transdermally to a subject a pharmaceutical of treating an inflammatory disease in an effective amount thereof,
- wherein an active ingredient exhibiting an anti-inflammatory activity in the pharmaceutical consists of:
- bromovalerylurea or a hydrate, solvate, isomer or a salt thereof, and
- the pharmaceutical is in a form of ointment, cream, or lotion for the transdermal administration.
Dependencies are inferred from the claim text.